ACC 2014 Report: Benefits of treating heart attack patients with a cheap drug
The 6-month follow-up data from the METOCARD-CNIC trial are published in the Journal of the American College of Cardiology.
The 6-month follow-up data from the METOCARD-CNIC trial are published in the Journal of the American College of Cardiology.
Use of the drug aleglitazar, which has shown the ability to lower glucose levels and have favorable effects on cholesterol, did not reduce the risk of cardiovascular death,… read more.
Report from the ACC Annual Scientific Meeting, 29 – 31 March 2014 in Washington. Angiotensin-converting-enzyme (ACE) inhibitors are associated with reduced mortality and cardiovascular events in patients… read more.
by Bruce Sylvester – Following a first ischemic stroke, patients who keep their blood pressure well controlled appear to halve their risk of a second stroke, researchers reported… read more.
Dysfunctional version of normally protective protein that makes HDL found to promote inflammation and coronary artery disease.
Dysfunctional version of normally protective protein that makes HDL found to promote inflammation and coronary artery disease.
by Bruce Sylvester: Newly developed contrast MRI can help physicians predict which atrial fibrillation people have the best chance of benefiting from catheter ablation, researchers reported on Feb…. read more.
Very good long-term results for Atrial Fibrillation catheter ablation across Europe. Sophia Antipolis, 18 February 2014: One-quarter of high risk patients do not receive anticoagulants after ablation of… read more.
Aging men weighing treatment should be warned about cardiovascular events. According to a statement issued today by the Endocrine Society, the risks and benefits of testosterone therapy for… read more.
Aspirin is still overprescribed for stroke prevention in atrial fibrillation (AF) despite the potential for dangerous side effects, according to research published today.
Researchers have discovered the fundamental biology of calcium waves in relation to heart arrhythmias. The findings published in Nature Medicine outlines the discovery of this fundamental physiological process that… read more.
by Bruce Sylvester – Researchers have developed a new method to predicting which patients with heart failure will do well with treatment and which patients will not.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.